EP4R has been shown to have increased expression in human cutaneous squamous cell carcinoma [16], and to be the most abundant EP receptor subtype in human urinary tract transitional cell carcinoma [17], and colorectal cancer [18], among others [15]. This evidence concerns the gene PTGER4 and urothelial carcinoma.